Home › Idiopathic Thrombocytopenic Purpura › Louisiana › New Orleans
Idiopathic Thrombocytopenic Purpura clinical trials in New Orleans, LA
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
RecruitingPhase 1/2
- Ochsner Clinic Foundation, New Orleans
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
RecruitingPhase 3
- Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011, New Orleans
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingPhase 3
- Tulane University, New Orleans
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Greenville, NC6 studies
- Washington, DC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- Portland, OR4 studies
- Cleveland, OH3 studies
- Cedar Rapids, IA3 studies
Other studies in New Orleans
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Prostate Cancer10 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Steatotic Liver Disease8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.